NCT05204342View on ClinicalTrials.gov

Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

CompletedOBSERVATIONAL
Enrollment

22,500

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Ovarian Cancer
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT05204342 - Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France | Biotech Hunter | Biotech Hunter